It is important to distinguish de novo CML-BP from Ph-positive ALL before allogeneic hematopoietic cell transplantation. The effect of BCR::ABL1 mutation status on outcomes of hematopoietic cell ...

Chronic myeloid leukemia (CML) is a type of blood cancer. CML is Philadelphia chromosome-positive (Ph+) when pieces of chromosomes 9 and 22 break off and swap places. This creates a new abnormal ...

Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...

A team of researchers led by Dr. Nyam-Osor Chimge and Dr. Michael Kahn has uncovered a critical survival mechanism in therapy-resistant leukemia stem cells (LSCs) in chronic myeloid leukemia (CML).

Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the ...

Immature ganulocytes, also called myeloblasts, are a type of young white blood cell. Unusual amounts of myeloblasts usually occur due to problems with bone marrow, such as certain types of blood ...

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care ...

Enliven's ELVN-001 is a high-potential investigational therapy with a best-in-class profile, offering a complementary ...

Leukemia is a blood cancer with abnormal white blood cell overproduction, affecting red blood cells and platelets, leading to anemia and infection risks. Diagnosis involves blood tests, bone marrow ...